Global Pharmatech (Global Pharmatech) FCF Margin % : 17.31% (As of Jun. 2008)

View and export this data going back to . Start your Free Trial

What is Global Pharmatech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Global Pharmatech's Free Cash Flow for the three months ended in Jun. 2008 was $0.13 Mil. Global Pharmatech's Revenue for the three months ended in Jun. 2008 was $0.73 Mil. Therefore, Global Pharmatech's FCF Margin % for the quarter that ended in Jun. 2008 was 17.31%.

As of today, Global Pharmatech's current FCF Yield % is 0.00%.

The historical rank and industry rank for Global Pharmatech's FCF Margin % or its related term are showing as below:

GBLP' s FCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 1.64
Current: 1.64

During the past 5 years, the highest FCF Margin % of Global Pharmatech was 1.64%. The lowest was 0.00%. And the median was 0.00%.

GBLP's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: -0.675 vs GBLP: 1.64

Global Pharmatech FCF Margin % Historical Data

The historical data trend for Global Pharmatech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Pharmatech FCF Margin % Chart

Global Pharmatech Annual Data

Trend

Mar03

Mar04

Dec05

Dec06

Dec07

FCF Margin %

-72.64

-7.19

-20.43

Global Pharmatech Quarterly Data
	Mar03	Mar04	Sep04	Dec04	Mar05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08
FCF Margin %	Get a 7-Day Free Trial												-80.97	-29.17	20.03	-23.93	17.31

Competitive Comparison of Global Pharmatech's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Global Pharmatech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Global Pharmatech's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Global Pharmatech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Global Pharmatech's FCF Margin % falls into.

Global Pharmatech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Global Pharmatech's FCF Margin for the fiscal year that ended in Dec. 2007 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2007 )	/	Revenue (A: Dec. 2007 )
	=	-0.576	/	2.819
	=	-20.43 %

Global Pharmatech's FCF Margin for the quarter that ended in Jun. 2008 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2008 )	/	Revenue (Q: Jun. 2008 )
	=	0.126	/	0.728
	=	17.31 %

Global Pharmatech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Global Pharmatech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Pharmatech (Global Pharmatech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Global Pharmatech Inc (OTCPK:GBLP) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 75, Fa Yuen Street, Mong Kok, Flat/RM 705, 7/F, Fa Yuen Commercial Building, Hong Kong, HKG

Website

http://www.global-pharmatech.com

Global Pharmatech Inc through its subsdiaries, discovers, develops, manufactures and markets proprietary drugs developed based on Traditional Chinese Medicine (TCM) while utilizing modern facilities and advanced R&D technologies. Geographically, the major business activities are carried out through People's Republic of China with sales distribution in China, Hong Kong, Singapore, Malaysia, Indonesia and USA.

Global Pharmatech (Global Pharmatech) Headlines

No Headlines